Related Experiment Videos

Soluble CD40L and its role in essential hypertension: diagnostic and therapeutic implications

Patrizia Ferroni1, Fiorella Guadagni

  • 1Department of Laboratory Medicine & Advanced Biotechnologies, IRCCS San Raffaele, Via della Pisana 235, Rome, Italy. patrizia.ferroni@sanraffaele.it

Cardiovascular & Hematological Disorders Drug Targets
|September 11, 2008
PubMed

Insights

Soluble CD40 ligand (sCD40L) is elevated in hypertension, linking inflammation and vascular damage. This review explores sCD40L

Area of Science:

  • Cardiovascular Biology
  • Hypertension Pathophysiology
  • Inflammatory Medicine

Background:

  • Soluble CD40 ligand (sCD40L) acts as a molecular link between inflammation, thrombosis, and angiogenesis in vascular damage.
  • Hypertension is increasingly recognized as an inflammatory disorder, highlighting the importance of the CD40/CD40L pathway.
  • The CD40/CD40L system serves as a versatile signaling pathway within vascular cells, integrating inflammatory signals.

Purpose of the Study:

  • To review the current understanding of soluble CD40 ligand's role in hypertension.
  • To elucidate the contribution of sCD40L to inflammation, thrombosis, and neoangiogenesis in the context of hypertension.
  • To discuss the impact of antihypertensive treatments on these sCD40L-mediated phenomena.

Main Methods:

  • Literature review summarizing current research on CD40/CD40L signaling in hypertension.
  • Analysis of studies investigating the link between angiotensin II, CD40/CD40L ligation, and vascular inflammation.
  • Examination of data on sCD40L levels in hypertensive patients and their association with cardiovascular risk.

Main Results:

  • Elevated sCD40L levels are observed in hypertensive patients.
  • sCD40L may serve as a biomarker for cardiovascular event risk in hypertensive individuals.
  • Angiotensin II can enhance CD40/CD40L-induced inflammatory activation in vascular cells.

Conclusions:

  • The CD40/CD40L system is a critical link in hypertension pathophysiology, connecting inflammation, thrombosis, and angiogenesis.
  • sCD40L is implicated in vascular damage associated with hypertension and may predict cardiovascular events.
  • Antihypertensive drugs may possess pleiotropic effects influencing the CD40/CD40L pathway.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...